• SENSEX 81,451.01
    -182.01 (--0.22%)
  • BANKNIFTY 55,749.70
    203.65 (+0.37%)
  • Suzlon Energy
    74.30 86.04(%)
  • Reliance Power
    60.50 60.50(%)
  • Swiggy
    338.00 617.00(%)
  • Mazagon Dock
    3,450.00 1,200.00(%)
  • Eternal Ltd
    243.00 304.50(%)
  • MMTC
    88.20 131.88(%)
  • Garden Reach Sh.
    2,926.85 1,148.10(%)
  • Waaree Energies
    2,956.60 1,808.65(%)
  • Indian Energy Ex
    203.20 244.35(%)
  • Bharat Dynamics
    2,096.00 2,096.00(%)
  • Engineers India
    239.00 304.00(%)
  • NBCC
    126.41 139.83(%)
  • IFCI
    66.71 35.67(%)
  • Muthoot Finance
    2,241.75 2,444.65(%)
  • HDFC Bank
    1,948.60 1,977.95(%)
  • LMW
    16,640.85 13,456.85(%)
  • Hind.Aeronautics
    4,962.00 3,045.95(%)
  • Pidilite Inds.
    3,127.25 3,414.40(%)
  • Infosys
    1,555.10 1,307.10(%)
  • Ola Electric
    48.07 45.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Piramal Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Piramal Ajay G
  • BSE Code : 76066.0
  • ISIN : INE0DK501011
206.30 1 (0.59%)
  • As on 02 Jun 2025 (EOD)

  • Today’s Low

    205.50

  • Today’s High

    209.70

  • Open

    206.00

  • Perv Close

    205.09

  • 52W Low

    136.10

  • 52W High

    307.90

Key Indicators

  • P/E(TTM)

    39.52

  • Mar.Cap (₹Cr.)

    27,350.18

  • Div & Yield %

    0.07

  • Book Value(₹)

    56.22

  • Debt-Equity Ratio

    0.59

  • AGM Date

    30-May-2025

  • EPS

    5.22

  • P/E Ratio

    39.52

Financials Ratios

  • Debt-Equity Ratio

    0.70

  • Mar.Cap (₹Cr.)

    27,350.18

  • RONW (%)

    0.22

  • ROCE (%)

    5.40

Score Board

  • Equity (₹ in Cr.)

    1,325.75

  • BV (₹)

    56.20

  • Sales( ₹ in Cr.)

    5,285.71

  • NP (in Cr.)

    691.40

  • NP Var(%)

    78.0

  • Div%

    1.0

  • CPS (₹)

    6.90

  • EPS (₹)

    5.20

  • Traded Value (₹ in Lakhs)

    27,350.18

  • 52 Week High

    307.90

  • 52 Week Low

    136.10

  • Price BSE

    206.0

  • Price NSE

    206.00

  • Market Capital( in Cr.)

    27,350.18

  • P/C Ratio

    29.90

  • P/E Ratio

    39.50

  • Price Vs.BV

    5.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 4,390.11 3,443.22 3,340.42 2,938.81 - -
Excise Duty 0.00 0.00 0.00 0.00 - -
Net Sales 4,390.11 3,443.22 3,340.42 2,938.81 - -
Other Income 202.06 341.07 224.79 216.20 - -
Stock Adjustments 61.62 -53.31 32.66 -57.86 - -
Total Income 4,653.79 3,730.98 3,597.87 3,097.15 - -
EXPENDITURE :            
Raw Materials 2,170.46 1,715.17 1,594.17 1,169.91 - -
Power and Fuel Cost 112.89 107.94 83.83 68.08 - -
Employee Cost 613.93 548.50 448.03 395.15 - -
Other Manufacturing Expenses 251.57 259.29 299.83 252.74 - -
Selling and Administration Expenses 504.34 485.63 427.82 258.75 - -
Miscellaneous Expenses 180.62 182.81 59.20 117.39 - -
Employee Benefit Expenses 613.93 548.50 448.03 395.15 - -
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 - -
Total Expenses 3,833.81 3,299.34 2,912.88 2,262.02 - -
Operating Profit 819.98 431.64 684.99 835.13 - -
Interest 107.10 115.87 57.29 4.71 - -
Gross Profit 712.88 315.77 627.70 830.42 - -
Depreciation 205.26 192.08 165.37 143.64 - -
Profit Before Tax 507.62 123.69 462.33 686.78 - -
Current Tax 112.48 38.77 110.82 104.98 - -
Fringe Benefit tax 0.00 0.00 0.00 0.00 - -
Deferred Tax 3.92 15.42 -16.03 10.30 - -
Reported Net Profit 391.22 69.50 367.54 571.50 - -
Extraordinary Items 3.34 -3.14 -10.64 15.44 - -
Adjusted Net Profit 387.88 72.64 378.18 556.06 - -
Adjustment below Net Profit -3.79 -2.59 31.70 -2.46 - -
P & L Balance brought forward 971.79 918.28 569.04 0.00 - -
Statutory Appropriations 0.00 0.00 0.00 0.00 - -
Appropriations 0.00 13.40 50.00 0.00 - -
P & L Balance carried down 1,359.22 971.79 918.28 569.04 - -
Dividend 0.00 0.00 0.00 0.00 - -
Preference Dividend 0.00 0.00 0.00 0.00 - -
Equity Dividend (%) 1.10 0.00 5.60 0.00 - -
Dividend Per Share(Rs) 0.11 0.00 0.56 0.00 - -
Earnings Per Share-Unit Curr 2.96 0.58 3.10 5.75 - -
Earnings Per Share(Adj)-Unit Curr 2.96 0.57 - - - -
Book Value 50.74 44.09 43.20 41.23 - -
Book Value(Adj)-Unit Curr 50.74 43.06 - - - -

Shareholding Pattern

  • Promoter Group

    34.95%

  • Public Share Holding

    64.71%

  • Custodian

    0.34%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 91,750,276 6.92 91,750,276 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,570,932 0.19 2,570,932 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 369,003,464 27.83 369,003,464 5
Others 0 0.00 0 0
Sub Total 463,324,672 34.95 463,324,672 17
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 10,481 0.00 10,481 3
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 238,663,700 18.00 238,663,700 1
Financial Institutions / Banks 9,868 0.00 9,868 3
Foreign Bank 1,332 0.00 1,332 1
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 178,863,291 13.49 178,863,291 181
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 23,706,547 1.79 23,706,547 16
Mutual Funds / UTI 168,748,079 12.73 168,748,079 25
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 3,457,515 0.26 3,457,515 27
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 613,460,813 46.27 613,460,813 257
2] Non Institution
Bodies Corporate 15,945,846 1.20 15,945,846 1,259
Clearing Members 3,852 0.00 3,852 12
Directors of their Relatives 189,079 0.01 189,079 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 17,315,548 1.31 17,315,548 2
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 14,189,354 1.07 14,189,354 6,078
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 5,321,707 0.40 5,321,707 5,395
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 47,459,925 3.58 47,459,925 686
Individuals holding nominal share capital up to Rs. 1 lakh 126,401,534 9.53 126,401,534 418,982
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 50,914 0.00 50,914 12
Others 3,228,564 0.24 3,228,564 1
Sub Total 244,408,293 18.44 244,408,293 432,566
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 4,554,352 0.34 4,554,352 3
Total Shares held by Custodians and against which Depository Receipts have been issued 4,554,352 0.34 4,554,352 3
Grand Total ( A + B + C ) 1,325,748,130 100.00 1,325,748,130 432,843

Company Background

Piramal Pharma LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Piramal Pharma Ltd
  • BSE Code : 76066.0
  • ISIN : INE0DK501011

  • Incorporation Year

    2020

  • Registered Office

    Ground Floor Piramal Ananta
    Agastya Corp.Park LBS MargKurl, Mumbai,
    Maharashtra-400070

  • Telephone

    91-22-3802-3000/4000

  • FAX

    91-22-3802 3884

  • Chairman

    Nandini Piramal

  • Managing Director

  • Company Secretary

    Tanya D'Costa

  • Auditor

    Deloitte Haskins & Sells LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Piramal Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Piramal Pharma 206.30 4,592.17 4,390.11 39.52 8.27
Abbott India 30,453.15 6,097.18 5,848.91 45.75 44.71
Astrazeneca Phar 7,965.20 1,330.33 1,295.53 205.34 33.26
P & G Health Ltd 5,775.85 1,166.89 1,151.26 40.53 39.76
Glaxosmi. Pharma 3,295.00 3,530.73 3,407.25 60.74 44.44
Cipla 1,464.85 17,645.00 16,574.34 22.94 20.10
Amrutanjan Healt 711.95 437.58 421.23 40.50 20.84
Fermenta Biotec. 311.95 315.24 307.09 13.58 4.10
Guj. Themis Bio. 307.95 174.19 169.82 68.74 44.82
Bliss GVS Pharma 131.10 638.96 605.46 20.02 11.19
Ambalal Sarabhai 37.87 11.70 3.81 16.18 1.92